Statins associated with an 88% increased risk of recurrence of bladder cancer

This study was published in BMC Cancer 2015 Mar 13;15:120

 

Study title and authors:

Can daily intake of aspirin and/or statins influence the behavior of non-muscle invasive bladder cancer? A retrospective study on a cohort of patients undergoing transurethral bladder resection.

Pastore A, Palleschi G, Fuschi A, Silvestri L, Al Salhi Y, Costantini E, Zucchi A, Petrozza V, de Nunzio C, Carbone A.

 

This study can be accessed at: http://www.ncbi.nlm.nih.gov/pubmed/25877676

Transurethral  bladder resection is a surgical procedure that is used both to diagnose bladder cancer and to remove cancerous tissue from the bladder.

This study aimed to evaluate the relationship between  non-muscle-invasive bladder cancer and statins or aspirin in patients submitted to transurethral bladder resection. The study, (which included 574 patients diagnosed with non-muscle-invasive bladder cancer), was divided into two main groups: treated (aspirin and/or statins) and untreated.

Regarding statins, the study found that patients who took statins had a 88% increased risk of recurrence of bladder cancer compared to patients who did not take statins.